Zimbabwe has declined a major US health deal worth 367 million US dollars (£272m) spanning five years because of the United States' request for sensitive data.
This rejection became public following a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesman has since explained that the United States was seeking health data for scientific study and commercial gain while refused to share the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged further talks to find a agreement suitable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Background
This rejection comes after a similar situation in neighbouring Kenya, where a court halted a related deal with the US following legal challenges were raised about the security of citizens' medical information.
Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government agreements to boost openness and accountability.
As per reports, 16 African countries have to date signed similar agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to share its biological resources and data indefinitely, without any corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"In essence, our country would supply the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our people should a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks previously set up through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.
"This framework is designed to ensure that when a country contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage further discussions with our US partners on how future collaboration might be designed in a way that honours the independence and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but recommended that negotiations must proceed given that much of the country's HIV programmes were funded by external financing.
"Where technical issues exist, such as those involving data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group said.
The situation emphasises the continuing challenges between accepting vital international aid and protecting local interests in an increasingly data-driven world.